Results for tag: "Zaltrap"

Zaltrap is a brand of colon cancer drug developed by Sanofi and Regeneron Pharmaceuticals. It is a monoclonal antibody that works by blocking the activity of vascular endothelial growth factor (VEGF), a protein that helps cancer cells grow and spread. Zaltrap is used in combination with chemotherapy to treat metastatic colorectal cancer in adults. It is approved by the U.S. Food and Drug Administration (FDA) and is available in the United States and Europe. The Zaltrap market is highly competitive, with several other drugs available to treat colon cancer. These include Avastin, Erbitux, and Stivarga. Each of these drugs has its own advantages and disadvantages, and physicians must weigh the risks and benefits of each drug when deciding which one to prescribe. Companies in the Zaltrap market include Sanofi, Regeneron Pharmaceuticals, Roche, Merck, and Bayer. Show Less Read more